Search Results - "Batuca, J R"

Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus by Batuca, J. R., Ames, P. R. J., Amaral, M., Favas, C., Isenberg, D. A., Delgado Alves, J.

“…Objective. To determine whether antibodies against high-density lipoprotein (aHDL) and apolipoprotein A-I (aApo A-I) interfere with the anti-atherogenic…”
Get full text

High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome by Ames, PRJ, Matsuura, E., Batuca, JR, Ciampa, A., Lopez, LL, Ferrara, F., Iannaccone, L., Delgado Alves, J.

“…Abnormalities of the lipid profile partly explain the atherogenic tendency of systemic lupus erythematosus but the picture is unclear in thrombotic primary…”
Get full text

Effect of efavirenz on high‐density lipoprotein antioxidant properties in HIV‐infected patients by Pereira, S. A., Batuca, J. R., Caixas, U., Branco, T., Delgado‐Alves, J., Germano, I., Lampreia, F., Monteiro, E. C.

“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • In previous work, we showed a long‐term and concentration‐dependent beneficial effect of the non‐nucleoside reverse…”
Get full text

Antibodies toward High-Density Lipoprotein Components Inhibit Paraoxonase Activity in Patients with Systemic Lupus Erythematosus by BATUCA, J. R., AMES, P. R. J., ISENBERG, D. A., DELGADO ALVES, J.

“…:  Patients with systemic lupus erythematosus (SLE) have an increased incidence of vascular disease, and oxidative stress is recognized as an important feature…”
Get full text

Investigator Initiated Clinical Trials (IICTs): A Systematic Search in Registries to Compare the Czech Republic and Portugal in Terms of Funding Policies and Scientific Outcomes by Madeira, C, Hořavová, L, Dos Santos, F, Batuca, J R, Nebeska, K, Součková, L, Kubiak, C, Demotes, J, Demlová, R, Monteiro, E C

“…Clinical trials provide one of the highest levels of evidence to support medical practice. Investigator initiated clinical trials (IICTs) answer relevant…”
Get more information

The role of high‐density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity by Fernandes das Neves, Marisa, Batuca, Joana R., Delgado Alves, José

“…Summary Inflammation and immune dysfunction have been increasingly recognized as crucial mechanisms in atherogenesis. Modifications in cell lipid metabolism,…”
Get full text

Functional characterization of phosphodiesterases 4 in the rat carotid body: effect of oxygen concentrations by Nunes, A R, Batuce, J R, Monterio, E C

“…The non-specific cAMP phosphodiesterase (PDE) inhibitor isobutyl- methylxanthine (IBMX) has been used to manipulate cAMP levels in carotid body (CB)…”
Get more information

157 Antibodies towards atp-binding cassette transporter abca1: a new mechanism for atherosclerosis in sle? by Neves, M Fernandes das, Batuca, JR, Batista, F, Favas, C, Henriques, C, Alves, J Delgado

“…Background and aimsSystemic Lupus Erythematosus (SLE) is considered an independent risk factor for cardiovascular disease. ATP-binding cassette transporter…”
Get full text